Identification
- Composition (DCI)
- méthotrexate
- Manufacturer
- SYNTHEMEDIC
- ATC code
- L01BA01
- Presentation
- Boite de 10 flacons de 20 ml
- Schedule / Reimb.
- A
- Hospital price
- 1071.00 MAD
Indications
- Traitement de néoplasies hématologiques comme la leucémie lymphatique aiguë et myéloïde et le lymphome non hodgkinien ainsi que de tumeurs solides telles que cancer du sein, carcinome bronchique, tumeurs malignes de la tête et du cou, ostéosarcome, choriocarcinome et autres tumeurs trophoblastiques, cancer de la vessie. - Traitement de maladies auto-immunes telles que la polyarthrite rhumatoïde. - Traitement du psoriasis sévère non maîtrisé, résistant au traitement classique.
Find an open pharmacy
On-call pharmacies near you
About METHOTREXATE MYLAN 25 MG / ML
METHOTREXATE MYLAN 25 MG / ML is marketed in Morocco by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of METHOTREXATE MYLAN 25 MG / ML, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about METHOTREXATE MYLAN 25 MG / ML
Answers to common questions from Moroccan patients about this drug.